Diagnostic difficulties of small intestinal neuroendocrine tumors: clinical case
- Authors: Kotelnikova L.P.1,2, Shatrova N.A.2, Trukhacheva E.A.2
-
Affiliations:
- E.A. Vagner Perm State Medical University
- Perm Krai Clinical Hospital
- Issue: Vol 39, No 5 (2022)
- Pages: 144-149
- Section: Clinical case
- URL: https://journals.rcsi.science/PMJ/article/view/112494
- DOI: https://doi.org/10.17816/pmj395144-149
- ID: 112494
Cite item
Full Text
Abstract
The objective of the study was to demonstrate the difficulties of diagnosing the neuroendocrine tumor (NET) of the small intestine at the example of a concrete clinical case. In the case presented, clinical manifestations of the disease were nonspecific and the examination began from a low-informative method – multispiral computed tomography (MSCT) without a bolus contrast study that was the reason of wrong diagnosis for 7 months. The detection of the swollen lymph node in the mesentery was interpreted incorrectly; additionally, only endoscopic investigation of the stomach and large intestine was used. By means of MSCT-angiography we succeeded to diagnose not only the lymph node conglomerate in the mesentery, but to reveal a tumor sized 9´15 cm in the ileac wall. Laparoscopy with lymph node biopsy after its morphological study permitted to verify the diagnosis before the surgery.
To reduce the period of diagnostics of small intestinal NET, general practitioners should be informed on specific features of clinical manifestations of the disease and rational diagnostic methods. MSCT-angiography showed its efficiency in detection of small-sized small intestinal NET, and laparoscopy with biopsy of the mesentery lymph node will permit to verify the diagnosis before surgery.
Full Text
##article.viewOnOriginalSite##About the authors
L. P. Kotelnikova
E.A. Vagner Perm State Medical University; Perm Krai Clinical Hospital
Author for correspondence.
Email: splaksin@mail.ru
MD PhD, Professor, Head of the Department of Surgery with Course of Cardiovascular Surgery and Invasive Cardiology
Russian Federation, Perm; PermN. A. Shatrova
Perm Krai Clinical Hospital
Email: splaksin@mail.ru
surgeon, 1st Surgical Unit
Russian Federation, PermE. A. Trukhacheva
Perm Krai Clinical Hospital
Email: splaksin@mail.ru
radiologist, Department of Computer Diagnostics
Russian Federation, PermReferences
- Durleshter V.M., Henrikh S.R., Avakimyan A.V., Dryyaeva L.H., Kirakosyan D.S. Experience of diagnosis and treatment of patients with intestinal neuroendocrine tumor. Nauchnyj vestnik zdravoohraneniya Kubani 2018; 2: 39–50.
- Lysanyuk M.V., Maistrenko N.A., Romashenko P.N. The difficulties of diagnosis and choice of treatment tactics of neuroendocrine tumors. Grekov’s Bulletin of Surgery 2018; 177 (1): 76–80.
- Lisanyuk M.V., Romashenko P.N., Maistrenko N.A. Features of diagnostics and treatment of patients with neuroendocrine tumors of the small intestine. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2020; 23 (2): 100–109.
- Beltsevich D.G., Melnichenko G.A. Management of patients with differentiated neuroendocrine tumors of jejunum and ileum (according to international guidelines). Endocrine Surgery 2011; 2: 5–17.
- Watzka F.M., Fotter C., Miederer M., Weber M.M., Schad A., Lang H., Musholt T.J. Surgical treatment of NEN og small bowel: a retrospective analysis. Wold J. Surg. 2016; 40 (3): 749–758.
- Fata C.R., Gonzalez R.S., Liu E., Cates J.M., Shi C. Mesenteric tumor in Endomidgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis. Am. J. Surg. Pathol. 2017; 41 (1): 128–133.
- Clift A.K., Kidd M., Bodei L., Toumpanakis C., Baum R.P., Oberg K., Modlin I.N., Frilling A. Neuroendocrine neoplasms of the small bowel and pancreas. Neuroendocrinology 2020; 110: 444–476.
- Sundin A., Arnold R., Baudin E., Cwikla J.B., Eriksson B., Fanti S., Fazio N., Giammarile F., Hicks R.J., Kjaer A., Krenning E., Kwekkeboom D., Lombard-Bohas C., O’Connor J.M., O’Toole D., Rockall A., Wiedenmann B., Valle J.W., Vullierme M. ENETS Consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine&hybrid imaging. Neuroendocrinology 2017; 105 (3): 121–244.
